BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 31322791)

  • 1. CAGI SickKids challenges: Assessment of phenotype and variant predictions derived from clinical and genomic data of children with undiagnosed diseases.
    Kasak L; Hunter JM; Udani R; Bakolitsa C; Hu Z; Adhikari AN; Babbi G; Casadio R; Gough J; Guerrero RF; Jiang Y; Joseph T; Katsonis P; Kotte S; Kundu K; Lichtarge O; Martelli PL; Mooney SD; Moult J; Pal LR; Poitras J; Radivojac P; Rao A; Sivadasan N; Sunderam U; Saipradeep VG; Yin Y; Zaucha J; Brenner SE; Meyn MS
    Hum Mutat; 2019 Sep; 40(9):1373-1391. PubMed ID: 31322791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matching whole genomes to rare genetic disorders: Identification of potential causative variants using phenotype-weighted knowledge in the CAGI SickKids5 clinical genomes challenge.
    Pal LR; Kundu K; Yin Y; Moult J
    Hum Mutat; 2020 Feb; 41(2):347-362. PubMed ID: 31680375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are machine learning based methods suited to address complex biological problems? Lessons from CAGI-5 challenges.
    Savojardo C; Babbi G; Bovo S; Capriotti E; Martelli PL; Casadio R
    Hum Mutat; 2019 Sep; 40(9):1455-1462. PubMed ID: 31066146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CAGI4 SickKids clinical genomes challenge: A pipeline for identifying pathogenic variants.
    Pal LR; Kundu K; Yin Y; Moult J
    Hum Mutat; 2017 Sep; 38(9):1169-1181. PubMed ID: 28512736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reports from the fifth edition of CAGI: The Critical Assessment of Genome Interpretation.
    Andreoletti G; Pal LR; Moult J; Brenner SE
    Hum Mutat; 2019 Sep; 40(9):1197-1201. PubMed ID: 31334884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CAGI5: Objective performance assessments of predictions based on the Evolutionary Action equation.
    Katsonis P; Lichtarge O
    Hum Mutat; 2019 Sep; 40(9):1436-1454. PubMed ID: 31317604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing predictions of the impact of variants on splicing in CAGI5.
    Mount SM; Avsec Ž; Carmel L; Casadio R; Çelik MH; Chen K; Cheng J; Cohen NE; Fairbrother WG; Fenesh T; Gagneur J; Gotea V; Holzer T; Lin CF; Martelli PL; Naito T; Nguyen TYD; Savojardo C; Unger R; Wang R; Yang Y; Zhao H
    Hum Mutat; 2019 Sep; 40(9):1215-1224. PubMed ID: 31301154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic and clinical utility of whole genome sequencing in a cohort of undiagnosed Chinese families with rare diseases.
    Liu HY; Zhou L; Zheng MY; Huang J; Wan S; Zhu A; Zhang M; Dong A; Hou L; Li J; Xu H; Lu B; Lu W; Liu P; Lu Y
    Sci Rep; 2019 Dec; 9(1):19365. PubMed ID: 31852928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of in silico tools for the evaluation of p16INK4a (CDKN2A) variants in CAGI.
    Carraro M; Minervini G; Giollo M; Bromberg Y; Capriotti E; Casadio R; Dunbrack R; Elefanti L; Fariselli P; Ferrari C; Gough J; Katsonis P; Leonardi E; Lichtarge O; Menin C; Martelli PL; Niroula A; Pal LR; Repo S; Scaini MC; Vihinen M; Wei Q; Xu Q; Yang Y; Yin Y; Zaucha J; Zhao H; Zhou Y; Brenner SE; Moult J; Tosatto SCE
    Hum Mutat; 2017 Sep; 38(9):1042-1050. PubMed ID: 28440912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lessons from the CAGI-4 Hopkins clinical panel challenge.
    Chandonia JM; Adhikari A; Carraro M; Chhibber A; Cutting GR; Fu Y; Gasparini A; Jones DT; Kramer A; Kundu K; Lam HYK; Leonardi E; Moult J; Pal LR; Searls DB; Shah S; Sunyaev S; Tosatto SCE; Yin Y; Buckley BA
    Hum Mutat; 2017 Sep; 38(9):1155-1168. PubMed ID: 28397312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Singapore Undiagnosed Disease Program: Genomic Analysis aids Diagnosis and Clinical Management.
    Bhatia NS; Lim JY; Bonnard C; Kuan JL; Brett M; Wei H; Cham B; Chin H; Bosso-Lefevre C; Dharuman P; Escande-Beillard N; Devasia AG; Goh CYJ; Kam S; Liew WK; Liew WK; Lin G; Jain K; Ng AY; Subramanian D; Xie M; Tan YM; Tawari NR; Tiang Z; Ting TW; Tohari S; Tong CK; Lezhava A; Ng SB; Law HY; Venkatesh B; Tomar S; Sethi R; Tan G; Shanmugasundaram A; Goh DL; Lai PS; Lai A; Tan ES; Ng I; Reversades B; Tan EC; Foo R; Jamuar SS;
    Arch Dis Child; 2021 Jan; 106(1):31-37. PubMed ID: 32819910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ensemble variant interpretation methods to predict enzyme activity and assign pathogenicity in the CAGI4 NAGLU (Human N-acetyl-glucosaminidase) and UBE2I (Human SUMO-ligase) challenges.
    Yin Y; Kundu K; Pal LR; Moult J
    Hum Mutat; 2017 Sep; 38(9):1109-1122. PubMed ID: 28544272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PON-P and PON-P2 predictor performance in CAGI challenges: Lessons learned.
    Niroula A; Vihinen M
    Hum Mutat; 2017 Sep; 38(9):1085-1091. PubMed ID: 28224672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical assessment of variant prioritization methods for rare disease diagnosis within the Rare Genomes Project.
    Stenton SL; O'Leary M; Lemire G; VanNoy GE; DiTroia S; Ganesh VS; Groopman E; O'Heir E; Mangilog B; Osei-Owusu I; Pais LS; Serrano J; Singer-Berk M; Weisburd B; Wilson M; Austin-Tse C; Abdelhakim M; Althagafi A; Babbi G; Bellazzi R; Bovo S; Carta MG; Casadio R; Coenen PJ; De Paoli F; Floris M; Gajapathy M; Hoehndorf R; Jacobsen JOB; Joseph T; Kamandula A; Katsonis P; Kint C; Lichtarge O; Limongelli I; Lu Y; Magni P; Mamidi TKK; Martelli PL; Mulargia M; Nicora G; Nykamp K; Pejaver V; Peng Y; Pham THC; Podda MS; Rao A; Rizzo E; Saipradeep VG; Savojardo C; Schols P; Shen Y; Sivadasan N; Smedley D; Soru D; Srinivasan R; Sun Y; Sunderam U; Tan W; Tiwari N; Wang X; Wang Y; Williams A; Worthey EA; Yin R; You Y; Zeiberg D; Zucca S; Bakolitsa C; Brenner SE; Fullerton SM; Radivojac P; Rehm HL; O'Donnell-Luria A
    medRxiv; 2023 Aug; ():. PubMed ID: 37577678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying digenic disease genes via machine learning in the Undiagnosed Diseases Network.
    Mukherjee S; Cogan JD; Newman JH; Phillips JA; Hamid R; ; Meiler J; Capra JA
    Am J Hum Genet; 2021 Oct; 108(10):1946-1963. PubMed ID: 34529933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Machine Learning of Patient Characteristics to Predict Admission Outcomes in the Undiagnosed Diseases Network.
    Amiri H; Kohane IS;
    JAMA Netw Open; 2021 Feb; 4(2):e2036220. PubMed ID: 33630084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Missed diagnoses: Clinically relevant lessons learned through medical mysteries solved by the Undiagnosed Diseases Network.
    Cope H; Spillmann R; Rosenfeld JA; Brokamp E; Signer R; Schoch K; Kelley EG; Sullivan JA; Macnamara E; Lincoln S; Golden-Grant K; ; Orengo JP; Clark G; Burrage LC; Posey JE; Punetha J; Robertson A; Cogan J; Phillips JA; Martinez-Agosto J; Shashi V
    Mol Genet Genomic Med; 2020 Oct; 8(10):e1397. PubMed ID: 32730690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parents perspectives on whole genome sequencing for their children: qualified enthusiasm?
    Anderson JA; Meyn MS; Shuman C; Zlotnik Shaul R; Mantella LE; Szego MJ; Bowdin S; Monfared N; Hayeems RZ
    J Med Ethics; 2017 Aug; 43(8):535-539. PubMed ID: 27888232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A fully-automated event-based variant prioritizing solution to the CAGI5 intellectual disability gene panel challenge.
    Chen J
    Hum Mutat; 2019 Sep; 40(9):1364-1372. PubMed ID: 31066479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CAGI, the Critical Assessment of Genome Interpretation, establishes progress and prospects for computational genetic variant interpretation methods.
    Critical Assessment of Genome Interpretation Consortium
    Genome Biol; 2024 Feb; 25(1):53. PubMed ID: 38389099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.